The official expressed hope on the success of the five vaccines that are under different phases of trial in the country.
Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of inflation and pricing pressures in the global markets. While R&D investment, market competitiveness, regulatory scrutiny, and domestic price regulations are expected to shape the growth of generics and injectable products, concerns such as price control and customs duties on medical equipment will continue to bother the healthcare industry in 2023. The industry believes that in view of India's G20 Presidency, digital health innovation, achieving universal health coverage, improving healthcare infrastructure and delivery will continue to be the key driving factors in 2023.
ONGC was the top loser in the Sensex pack, shedding around 5 per cent, followed by SBI, Axis Bank, ICICI Bank, Bajaj Auto and Maruti. On the other hand, IndusInd Bank, HUL, Dr Reddy's, NTPC and Reliance Industries were among the gainers.
Titan was the top gainer in the Sensex pack, rising over 3 per cent, followed by M&M, Reliance Industries, Axis Bank, TCS, Maruti and Infosys. NSE Nifty surged 122.10 points to 15,885.15.
When compared to the domestic sales of April 2019, the growth is around 37 per cent. However, compared to the previous month (March), the growth is 18.4 per cent.
Asked if the government has decided to administer the COVID-19 vaccine to the entire population free of cost on priority basis and if so, the target fixed to administer the doses, the health minister said according to Revised Guidelines for Implementation of National COVID Vaccination Program, which came into effect from June 21, all citizens aged 18 years and above, irrespective of their income status, are entitled to free vaccination at all government vaccination centres.
Several Union ministers, including Health Minister Dr Harsh Vardhan, Education Minister Ramesh Pokhriyal Nishank and Labour Minister Santosh Gangwar resigned.
10 non-bank and non-finance stocks from the BSE500 Index universe that offer an optimal blend of low valuation, reasonably robust revenue and earnings growth in recent quarters, a strong balance sheet, and most importantly, positive cash flow from their operations.
Justice Suresh Kait, who was hearing Chidambaram's interim bail plea, directed the Tihar jail superintendent to provide clean and hygienic surrounding to the 74-year old Congress leader as also home-cooked food, mineral water, mosquito protection net and repellent
ONGC was the top loser in the Sensex pack, shedding around 5 per cent, followed by Sun Pharma, PowerGrid, Bajaj Finance, IndusInd Bank, Dr Reddy's and Maruti. On the other hand, Reliance Industries, Titan, HDFC Bank and ITC were the gainers.
Experts say the stock market correction in recent times increases the risk-reward in favour of large-cap stocks.
As per RDIF, Sputnik V has a number of key advantages, including that there are no strong allergies caused by Sputnik V.
Some of our leaders were busybusy over the weekend.
Of the 30-share Sensex, 13 ended higher, while 17 led by Power Grid, Tata Steel, Bajaj Auto, Hero MotoCorp, NTPC, Tata Motors, Dr Reddy's, M&M, GAIL, Infosys and L&T finished lower, fell by up to 2.40 per cent
PowerGrid was the top gainer in the Sensex pack, rallying over 4 per cent, followed by NTPC, UltraTech Cement, Tech Mahindra, Reliance Industries and IndusInd Bank.
The prime minister was happy that the assurance given by the Serum Institute that it will make India self-sufficient in vaccines at the lowest possible price in the world was fulfilled.
'Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization for its COVID-19 vaccine in India'
For 2017-18 and 2018-19, investors are better off focusing on the quality of measures announced in the Budget and outside it rather than on the Budget numbers themselves, says T T Ram Mohan.
Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.
The benchmark indices fell as Sebi cracked down on 331 suspected shell companies listed on exchanges.
The government was hoping to roll out the GST regime from April 2016.
Here's looking at other Presidents who have travelled by train.
Samajwadi Party patriarch Mulayam Singh Yadav is among six personalities chosen for this year's Padma Vibhushan.
Once a difficult market to crack, in recent years, China has relatively opened up its drug market, enacting reforms and speeding up approval time.
The recent recalls come amid increased FDA scrutiny of medicines produced in India.
Questioning the team's authority headed by a former Patna high court judge, Banerjee pointed out that Ram Navami processions organised by the Bharatiya Janata Party had carried arms and driven tractors and deliberately taken routes where 'Namaz' was being offered.
The S&P BSE Sensex surged 364 points to end at 24,607 and the Nifty50 soared 107 points to close at 7,476.
Sharma was the president of the conference, the first since the Paris Agreement of COP21 that expected parties to make enhanced commitments towards mitigating climate change.
Superstar Krishna passed into the ages on November 15, sending the Telugu film industry in a state of mourning.
The Sports Authority of India on Friday formed a three-member inquiry committee to look into gymnast Aruna Budda Reddy's allegations of being video-graphed without consent during a physical fitness test conducted in March.
US District Judge Beryl Howell in Minneapolis denied Ranbaxy's request, the court filing showed.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
What some of our political leaders were up to on Monday.
Asia's falling stocks have triggered an exodus of funds from the region.
The 'Agni P' is a two-stage canisterised solid propellant ballistic missile with dual redundant navigation and guidance system.
Among key stocks, Tata Motors, Hero MotoCorp, L&T, Wipro, ICICI Bank, Dr Reddy's Labs and ICICI Bank, all up between 1%-3%
Ajit Mishra, vice president, Research, Religare Broking, answers your stock market queries.
Markets closed in the red on domestic worries.
The Serum Institute of India, Bharat Biotech and Pfizer have applied to the DCGI seeking emergency use authorisation for their COVID-19 vaccine candidates and are awaiting approval.
A back of the envelope calculation shows that India has roughly over 680 million doses of Covid-19 vaccines consisting primarily of Covishield doses.
